Serum KL-6 levels are elevated in SSc patients with ILD compared with SSc patients without ILD and are inversely correlated with a forced vital capacity (FVC) and a diffusing capacity for carbon monoxide (DLCO) in patients with SSc-ILD. The gene discussed is MUC1; the disease is systemic sclerosis.